Terms: = Liver cancer AND CALCB, Calcitonin AND Treatment
63 results:
1. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract] [Full Text] [Related]
2. Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation.
Kong L; Xiong Y; Wang D; Huang L; Li M; Feng Z; Zhou Y; Zhang H; Liu F; Xiao F; Wei Y; Zhang W
Breast Cancer Res Treat; 2022 Sep; 195(2):91-103. PubMed ID: 35896852
[TBL] [Abstract] [Full Text] [Related]
3. Prospective study on the clinical relevance of
Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic Medullary Thyroid cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Hayes AR; Crawford A; Al Riyami K; Tang C; Bomanji J; Baldeweg SE; Wild D; Morganstein D; Harry A; Grozinsky-Glasberg S; Oleinikov K; Khoo B; Caplin ME; Nicolas GP; Grossman AB
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4903-e4916. PubMed ID: 34379772
[TBL] [Abstract] [Full Text] [Related]
5. Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade.
Xiao F; Li H; Feng Z; Huang L; Kong L; Li M; Wang D; Liu F; Zhu Z; Wei Y; Zhang W
Sci Rep; 2021 Jan; 11(1):488. PubMed ID: 33436794
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide.
Huang L; Wang D; Feng Z; Zhao H; Xiao F; Wei Y; Zhang H; Li H; Kong L; Li M; Liu F; Zhang H; Zhang W
Mol Cancer Ther; 2021 Feb; 20(2):284-295. PubMed ID: 33298587
[TBL] [Abstract] [Full Text] [Related]
7. Breast metastasis from medullary thyroid carcinoma mimicking ductal carcinoma with neuroendocrine differentiation.
Laforga JB; Dominguez E; Aranda FI
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1292. PubMed ID: 33025739
[TBL] [Abstract] [Full Text] [Related]
8. The Neuropeptide System and Colorectal cancer liver Metastases: Mechanisms and Management.
Kasprzak A; Adamek A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429087
[TBL] [Abstract] [Full Text] [Related]
9. Neuroendocrine tumor with diarrhea: not always the usual suspects - a case report of metastatic calcitoninoma with literature review.
Vlaemynck K; De Man M; De Man K; Hoorens A; Geboes K
Acta Clin Belg; 2021 Jun; 76(3):239-243. PubMed ID: 31900071
[TBL] [Abstract] [Full Text] [Related]
10. A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space.
Lajud SA; Aponte-Ortiz JA; Garraton M; Giraldez L
J Robot Surg; 2020 Feb; 14(1):233-236. PubMed ID: 30689166
[TBL] [Abstract] [Full Text] [Related]
11. Medullary thyroid carcinoma with breast metastasis: Two case reports.
Meng K; Chen W; Tian W; Sun K; Chen H
Medicine (Baltimore); 2018 Nov; 97(47):e13193. PubMed ID: 30461619
[TBL] [Abstract] [Full Text] [Related]
12. Selective RET kinase inhibition for patients with RET-altered cancers.
Subbiah V; Velcheti V; Tuch BB; Ebata K; Busaidy NL; Cabanillas ME; Wirth LJ; Stock S; Smith S; Lauriault V; Corsi-Travali S; Henry D; Burkard M; Hamor R; Bouhana K; Winski S; Wallace RD; Hartley D; Rhodes S; Reddy M; Brandhuber BJ; Andrews S; Rothenberg SM; Drilon A
Ann Oncol; 2018 Aug; 29(8):1869-1876. PubMed ID: 29912274
[TBL] [Abstract] [Full Text] [Related]
13. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor.
Valdes-Socin H; Almanza MR; Fernández-Ladreda MT; Daele DV; Polus M; Chavez M; Beckers A
Arch Endocrinol Metab; 2017; 61(5):506-509. PubMed ID: 28977163
[TBL] [Abstract] [Full Text] [Related]
14. Late liver metastasis of medullary thyroid cancer with low calcitonin levels - successfully cured by radiofrequency.
Al-Salameh A; Baudry C; Gautier JF; Toubert ME; Bihan H; Cohen R
Endokrynol Pol; 2016; 67(3):326-9. PubMed ID: 26884307
[TBL] [Abstract] [Full Text] [Related]
15. Medullary Thyroid Carcinoma: Imaging.
Delorme S; Raue F
Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
[TBL] [Abstract] [Full Text] [Related]
16. TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
El Hage F; Durgeau A; Mami-Chouaib F
Ann N Y Acad Sci; 2013 Apr; 1283():75-80. PubMed ID: 23302073
[TBL] [Abstract] [Full Text] [Related]
17. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
[TBL] [Abstract] [Full Text] [Related]
18. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
Alves C; Lima R
J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
[TBL] [Abstract] [Full Text] [Related]
19. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract] [Full Text] [Related]
20. Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.
Kraeber-Bodéré F; Salaun PY; Oudoux A; Goldenberg DM; Chatal JF; Barbet J
Cancer; 2010 Feb; 116(4 Suppl):1118-25. PubMed ID: 20127952
[TBL] [Abstract] [Full Text] [Related]
[Next]
